CVS pulls Zantac over cancer fears

Video Credit: Rumble
Published on October 1, 2019 - Duration: 00:41s

CVS pulls Zantac over cancer fears

CVS said over the weekend it will discontinue sales the popular Zantac heartburn treatment and its own generic ranitidine products from its pharmacies after traces of possible carcinogen amounts N-nitrosodimethylamine (NDMA) were found in some of the products by the U.S. Food and Drug Administration.

Gavino Garay reports.


You are here

You might like